The Oncosearch | Oncotarget

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment Research Paper

Sindy Vrecko, David Guenat, Patricia Mercier-Letondal, Hugues Faucheu, Magalie Dosset, Bernard Royer, Jeanne Galaine, Romain Boidot, Stefano Kim, Marine Jary, Olivier AdotÃ©vi, Christophe Borg, Yann Godet

Published Oct 23, 2018 · Vol. 9, No. 83 · pp. 35394-35407

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Xuguang Zhu, Erik Holmsen, Sunmi Park, Mark C. Willingham, Jun Qi, Sheue-yann Cheng

Published Oct 23, 2018 · Vol. 9, No. 83 · pp. 35408-35421

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Amro Aboukameel, Irfana Muqbil, Erkan Baloglu, William Senapedis, Yosef Landesman, Christian Argueta, Michael Kauffman, Hua Chang, Trinayan Kashyap, Sharon Shacham, Jasper E. Neggers, Dirk Daelemans, Elisabeth I. Heath, Asfar S. Azmi

Published Oct 19, 2018 · Vol. 9, No. 82 · pp. 35327-35342

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Frank Griesinger, Julia Roeper, Christoph PÃ¶ttgen, Kay C. Willborn, Wilfried E.E. Eberhardt

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35181-35194

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

Martin Rupp, Zhor Senhaji Mouhri, Christopher Williams, Bertrand J. Jean-Claude

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35041-35055

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

Hanna Engqvist, Toshima Z. Parris, Elisabeth Werner RÃ¶nnerman, Elin M.V. SÃ¶derberg, Jana Biermann, Claudia Mateoiu, Karin Sundfeldt, AnikÃ³ KovÃ¡cs, Per Karlsson, Khalil Helou

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35162-35180

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

Christian Posch, Martina Sanlorenzo, Jeffrey Ma, Sarasa T. Kim, Mitchell Zekhtser, Susana Ortiz-Urda

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34990-34995

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML Research Paper

Salma A. Bargal, Roya Rafiee, Kristine R. Crews, Huiyun Wu, Xueyuan Cao, Jeffrey E. Rubnitz, Raul C. Ribeiro, James R. Downing, Stanley B. Pounds, Jatinder K. Lamba

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34859-34875

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients Research Paper

Alexandra Samsen, Silvia von der Heyde, Carsten Bokemeyer, Kerstin A. David, Bernd Flath, Max Graap, Bianca Grebenstein, Ludger Heflik, Wiebke Hollburg, Peter Layer, Eike von Leitner, Friedrich Overkamp, Wolfgang Saeger, Sandra Schneider, Cay-Uwe von Seydewitz, Axel Stang, Alexander Stein, Carsten Zornig, Hartmut Juhl

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34794-34809

Surrogate endpoints in advanced sarcoma trials: a meta-analysis Meta-Analysis

Marion Savina, Saskia LitiÃ¨re, Antoine Italiano, Tomasz Burzykowski, Franck Bonnetain, Sophie Gourgou, Virginie Rondeau, Jean-Yves Blay, Sophie Cousin, Florence Duffaud, Hans Gelderblom, Alessandro Gronchi, Ian Judson, Axel Le Cesne, Paul Lorigan, Joan Maurel, Winette van der Graaf, Jaap Verweij, Simone Mathoulin-PÃ©lissier, Carine Bellera

Published Oct 2, 2018 · Vol. 9, No. 77 · pp. 34617-34627

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

Maria Quanz, Urs B. Hagemann, Sabine Zitzmann-Kolbe, Beatrix Stelte-Ludwig, Sven Golfier, Cem Elbi, Dominik Mumberg, Karl Ziegelbauer, Christoph A. Schatz

Published Sep 25, 2018 · Vol. 9, No. 75 · pp. 34103-34121

Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity Research Paper

Soyoko Morimoto, Fumihiro Fujiki, Kenta Kondo, Hiroko Nakajima, Yoshiki Kobayashi, Miki Inatome, Nao Aoyama, Yuya Nishida, Akihiro Tsuboi, Yoshihiro Oka, Sumiyuki Nishida, Jun Nakata, Naoki Hosen, Yusuke Oji, Haruo Sugiyama

Published Sep 25, 2018 · Vol. 9, No. 75 · pp. 34132-34141

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper

Dennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, Carmen Behrens, Neda Kalhor, Huiqin Chen, Li Shen, J. Jack Lee, Waun Ki Hong, Ximing Tang, Luc Girard, John D. Minna, Lixia Diao, Jing Wang, Barbara Mino, Pamela Villalobos, Jaime Rodriguez-Canales, Nana E. Hanson, James Sun, Vincent Miller, Joel Greenbowe, Garrett Frampton, Roy S. Herbst, Veera Baladandayuthapani, Ignacio I. Wistuba, Julie G. Izzo

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33995-34008

Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents Research Paper

Emma J. Jordan, James Spicer, Debashis Sarker

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33961-33971

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Hongyan Yuan, Levy Kopelovich, Yuzhi Yin, Jin Lu, Robert I. Glazer

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33866-33866

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Shogo Okazaki, Subaru Shintani, Yuki Hirata, Kentaro Suina, Takashi Semba, Juntaro Yamasaki, Kiyoko Umene, Miyuki Ishikawa, Hideyuki Saya, Osamu Nagano

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33832-33843

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Mathilde Guerin, Anthony GonÃ§alves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, Samuel Granjeaud, Patrick Fourquet, William Jacot, Carole Tarpin, Renaud Sabatier, Emilie Agavnian, Pascal Finetti, JosÃ© Adelaide, Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Patrice Viens, FranÃ§ois Bertucci, Jean-Paul Borg, Luc Camoin

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33762-33777

Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review Clinical Research Papers

Xiaofeng Li, Yueming He, Jinfeng Zhu, Hongxia Pang, Yongwei Lin, Jinyang Zheng

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33734-33738

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Francesca De Felice, Giancarlo Dâ€™Ambrosio, Daniela Musio, Franco Iafrate, Ilaria Benevento, Marco Marzo, Marialaura Mancini, Federica Urbano, Marcella Iannitti, Francesco Marampon, Nadia Bulzonetti, Enrico Cortesi, Vincenzo Tombolini

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33702-33709

Generation and characteristics of a novel â€œdouble-hitâ€ high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies Research Paper

Hiroaki Kikuchi, Tomonori Higuchi, Yumiko Hashida, Ayuko Taniguchi, Mikio Kamioka, Takahiro Taguchi, Akihito Yokoyama, Ichiro Murakami, Mikiya Fujieda, Masanori Daibata

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33482-33499

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment Research Paper

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML Research Paper

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients Research Paper

Surrogate endpoints in advanced sarcoma trials: a meta-analysis Meta-Analysis

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity Research Paper

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper

Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents Research Paper

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review Clinical Research Papers

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Generation and characteristics of a novel â€œdouble-hitâ€ high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment Research Paper

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression Research Paper

Brain metastases in ALK-positive NSCLC â€“ time to adjust current treatment algorithms Review

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival Research Paper

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML Research Paper

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients Research Paper

Surrogate endpoints in advanced sarcoma trials: a meta-analysis Meta-Analysis

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models Research Paper

Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity Research Paper

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer Research Paper

Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents Research Paper

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy Errata

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review Clinical Research Papers

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Generation and characteristics of a novel â€œdouble-hitâ€ high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies Research Paper

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

Generation and characteristics of a novel â€œdouble-hitâ€ high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies Research Paper